Skip to main content
Clinical Trials/NCT05997251
NCT05997251
Completed
Not Applicable

The Relationship of DASH and Mediterranean Diet Score With Serum Adiponectin Levels in Patients With Spinal Cord Injury

Ankara City Hospital Bilkent1 site in 1 country66 target enrollmentMarch 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spinal Cord Injuries
Sponsor
Ankara City Hospital Bilkent
Enrollment
66
Locations
1
Primary Endpoint
Adiponectin level
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study is to reveal the relationship of DASH and Mediterranean diet score with anthropometric measurements and serum adiponectin level in individuals with spinal cord injury. This research was planned as a cross-sectional, case-control study. With the data to be obtained from the research, information will be obtained about the hormonal or biochemical basis of metabolic disorders such as atherosclerosis and insulin resistance that may occur in individuals with spinal cord injury in the long term.

20 individuals with Spinal Cord Injury will be included in the study, and the results of the patients will be compared with 20 healthy individuals. In order to determine the food consumption status of the patients, a 1-day food consumption record will be requested. DASH diet score and Mediterranean diet score will be calculated from dietary records. After 8 hours of fasting, 3 ml of peripheral blood will be taken for the measurement of adiponectin between 08:00 and 09:00 in the morning from the individuals in the study and control groups. Adiponectin level will be measured and its correlation with DASH diet score and Mediterranean diet score will be examined.

Registry
clinicaltrials.gov
Start Date
March 1, 2021
End Date
March 1, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Emre Adıgüzel

MD

Ankara City Hospital Bilkent

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria (Study group)
  • Having spent at least 6 months after spinal cord injury
  • 1st motor neuron injury
  • Being between the ages of 18-65
  • Giving consent to participate in the study Inclusion criteria (Control group)
  • Being between the ages of 18-65
  • Giving consent to participate in the study

Exclusion Criteria

  • Exclusion criteria (Study group)
  • Having an additional disease to the spinal cord injury
  • Having a 2nd motor neuron lesion
  • Exclusion criteria (Control group)
  • Having any disease

Outcomes

Primary Outcomes

Adiponectin level

Time Frame: Will be measured at inclusion

Adiponectin level will be measured from peripheral blood

Mediterrenian diet score

Time Frame: Will be measured at inclusion from one day dietary record

Will be measured at inclusion from one day dietary record

DASH diet score

Time Frame: Will be measured at inclusion from one day dietary record

Will be measured at inclusion from one day dietary record

Secondary Outcomes

  • Fasting blood glucose(Will be measured at inclusion)
  • HDL(Will be measured at inclusion)
  • TG(Will be measured at inclusion)
  • Whole blood count(Will be measured at inclusion)
  • Total cholesterol(Will be measured at inclusion)
  • LDL(Will be measured at inclusion)

Study Sites (1)

Loading locations...

Similar Trials